WBD posts
FeedPosted Mar 17th 2009 11:00AM by Eric Buscemi (RSS feed)
Filed under: Analyst reports, Analyst upgrades and downgrades, Home Depot (HD), Citigroup Inc. (C), JPMorgan Chase (JPM), Bank of America (BAC), Goldman Sachs Group (GS), Morgan Stanley (MS), Analyst initiations, Garmin Ltd (GRMN)
Analyst upgrades:
- Jefferies upgraded Home Depot (NYSE: HD) to Buy from Hold as they expect significant multiple expansion as earnings revisions start to bottom out and the market starts to factor in a recovery. The firm raised its price target to $24 from $18-$20.
- Goldman upgraded HSBC (NYSE: HBC) to Neutral from Sell and removed the stock from their Asia Pacific Sell List given the company's plans to stop making new loans at its U.S. unit.
- Deutsche Bank upgraded Ensco International (NYSE: ESV) to Hold from Sell on valuation as it believes weakening shallow water demand is priced into shares at current levels. The firm raised its target price to $32 from $30.
- Liberty Global (NASDAQ: LBTYA) was raised to Equal Weight from Underweight at Morgan Stanley.
- UnitedHealth (NYSE: UNH) was lifted to Outperform from Market Perform at Bernstein.
Continue reading Analyst upgrades, downgrades and initiations: HD, HBC, GS, MS, BAC, JPM, C ...
Posted Aug 27th 2008 11:58AM by Eric Buscemi (RSS feed)
Filed under: Analyst reports, Analyst upgrades and downgrades, Analyst initiations
Analyst upgrades:
- Goldman upgraded shares of British Sky Broadcasting (NYSE: BSY) to Buy from Neutral and added the company to the Conviction Buy List as they find the stock oversold at current levels.
- Goldman also added Publicis (OTC: PUBGY) to the Conviction Buy List and upgraded shares to Buy from Neutral as they find the stock cheap at current levels.
- Oneok (NYSE: OKE) was upgraded to Overweight from Equal Weight at Lehman.
- UBS raised Wimm-Bill-Dann Foods (NYSE: WBD) to Buy from Neutral.
Analyst downgrades:
- Baird downgraded Amylin Pharma (NASDAQ: AMLN) to Neutral from Outperform and said they are incrementally more cautious on the commercial performance of Amylin's Byetta following the yesterday's update. Amylin's target was lowered to $27 from $37. Soleil recommends investors avoid Amylin with the disclosure last night of four additional cases of mortality associated with pancreatitis in patients who were on Byetta. The firm cut shares to Sell from Hold and lowered their target to $20 from $25.
- Citigroup downgraded shares of AMR Corp. (NYSE: AMR) to Sell from Hold on valuation as they find the stock expensive following the recent run-up. The firm raised their target to $9 from $6.70 to reflect the drop in crude prices.
- J Crew (NYSE: JCG) was downgraded to Hold from Buy at Brean Murray following the weak Q2 report and guidance.
- JMP Securities downgraded Quality Systems (NASDAQ: QSII) to Market Perform from Outperform.
- National Grid (NYSE: NGG) was lowered to Equal Weight from Overweight at Lehman.
Analyst initiations:
Continue reading Analyst calls: AMR, JCG, AMLN, NGG . . .
Posted Aug 1st 2008 11:10AM by Steven Halpern (RSS feed)
Filed under: International markets, Russia, Newsletters, Stocks to Buy
"In Russia, as in many other emerging markets, a new crop of homegrown companies is on the rise," says global expert John Christy, editor of The Forbes International Investment Report.
He says, "While relatively unknown outside their home markets, these firms have proven to be worthy competitors against much bigger multinationals." Here's a look at Wimm-Bill-Dann Foods (NYSE: WBD).
"In a research report in March, the Boston Consulting Group (BCG) called these emerging companies 'Local Dynamos'. Wimm-Bill-Dann Foods was one of just three Russian companies to qualify for BCG's exclusive list. WBD is Russia's largest food and beverage company.
"It has a whopping 76% market share for dairy products like milk and yogurt.It is the #3 player in beverages,mainly fruit juices,and it has the #1 market share for baby food in Russia.
"In developed markets, selling baby food and fruit juice is a mature,ifnot mundane business.But in Russia,these can still be considered relatively attractive growth opportunities.
Continue reading Wimm-Bill-Dann (WBD): Russia's largest food & beverage bet
Posted Jun 8th 2008 9:10AM by Trey Thoelcke (RSS feed)
Filed under: Earnings reports, , Nucor Corp (NUE), Toll Brothers (TOL), Smithfield Foods (SFD), Wells Fargo (WFC)
Here are some highlights from this past week's earnings coverage from BloggingStocks:
See also: Earnings highlights: Wal-Mart, Lehman Bros., Take-Two, Ciena, Trina Solar and others
Also, continued real estate losses are expected to hurt the quarterly reports of banks such as like Wachovia (NYSE: WB), Wells Fargo (NYSE: WFC), and National City (NYSE: NCC). And Steven Mallas wonders why Playboy (NYSE: PLA) shares have tanked since its last earnings report.
Upcoming results to watch for include Krispy Kreme (NYSE: KKD), Pall Corp. (NYSE: PLL), Pep Boys (NYSE: PBY), Korn Ferry (NYSE: KFY), and Casey's General Stores (NASDAQ: CASY).
Visit AOL Money & Finance for more earnings coverage.
Posted Jun 7th 2008 2:40PM by Steven Mallas (RSS feed)
Filed under: Earnings reports, Coca-Cola (KO), PepsiCo (PEP)
Earnings season is basically over, but there are still some reports out there. On Friday, Wimm-Bill-Dann (NYSE: WBD), a dairy and juice distributor based in Russia, divulged its Q1 earnings stats. Talk about growth across the board. Everything was double-digit appreciation (except for one metric, which I'll get to in just a minute).
Seriously, this is like a picture of perfection in many ways. Net revenues jumped 35%. Gross profit shot up 26%. Operating income soared 23%. Net income on a dollar basis rose 31%. Net income on a diluted basis increased 30% to $0.95 per share. Bravo, Wimm-Bill-Dann!
Now, there's one metric that the company didn't shine on. It can be found in the statement of cash flows. Net cash from operating activities actually declined 45%. Okay, cash flow is one of my favorite metrics, so yes, this decrease isn't a joyous event for me. But this is just the first quarter. The growth rates in the other areas nevertheless inspire confidence in this foreign company. Plus, according to Reuters, this quarterly performance beat expectations.
Continue reading Wimm-Bill-Dann has an incredible quarter of growth -- should you buy?
Posted Mar 13th 2008 11:26AM by Eric Buscemi (RSS feed)
Filed under: Analyst reports, Analyst upgrades and downgrades
MOST NOTEWORTHY: Monsanto, AstraZeneca and Millenium Pharmaceutical were today's noteworthy upgrades:
- Banc of America upgraded shares of Monsanto (NYSE: MON) to Buy from Neutral as they have grown more comfortable with two previous concerns: competition and valuation. They see an attractive entry point ahead of strong expected results for Q2.
- UBS upgraded shares of AstraZeneca (NYSE: AZN) to Neutral from Sell on valuation, as they believe many of the risks are priced into shares at current levels.
- Piper upgraded Millenium Pharma (NASDAQ: MLNM) to Buy from Neutral and added shares to their Alpha List ahead of additional front-line Velcade presentations at ASCO and expected front-line Velcade approval by June 20.
OTHER UPGRADES:
Posted Sep 12th 2007 10:40AM by Eric Buscemi (RSS feed)
Filed under: Analyst reports, Analyst upgrades and downgrades
MOST NOTEWORTHY: Sunoco, Primedia, WPP Group, Publicis and Newfield Exploration were today's noteworthy downgrades:
- Sunco Inc (NYSE: SUN) was downgraded to Neutral from Buy at Banc of America, as the firm believes Sunoco's valuation discount is justified since its net margin/barrel is almost $2.50 below its closest peer due to inferior assets.
- Deutsche Bank downgraded shares of Primedia Inc (NYSE: PRM) to Hold from Buy on valuation.
- Citigroup downgraded shares of WPP Group (NASDAQ: WPPGY) to Hold from Buy and shares of Publicis Groupe (NYSE: PUB) to Sell from Hold to reflect their more cautious view of the advertising sector.
- Goldman sees better catalysts at other E&Ps and downgraded Newfield Exploration Company (NYSE: NFX) to Neutral from Buy.
OTHER DOWNGRADES: